Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Do you live under a rock??

<< Previous

Bullboard Posts

Next >>

Comment by juicyjmillson Nov 24, 2020 1:50pm

182 Views

Post# 31962052

RE:RE:RE:RE:Do you live under a rock??

10x doesn't mean im doing well. I come from absolutely nothing. If it wasn't for people helping other people make smart decisions in the market, I would still be struggling to afford my next meal. Give what you want to recieve. It's foolish to be heavy in a startup biotech during the great financial reset and CEO's of big corps have already made it apparent they are dumping the stock market come time. By then you will be buying digital assets just to save yourself. I hope for everyones sake this stock survives, but I can almost promise you it wont. Anyone who knows my track record knows I tend to be wrong ;) so dont listen to me .... ;P

<< Previous

Bullboard Posts

Next >>

Online behaviour puts Canadians at risk of cyberattacks, study finds